Global Markets for Minimally Invasive Vertebral Compression Fracture Treatments 2010

This publication has been discontinued on May 11, 2011.

Below is the updated product.

Global Markets for Minimally Invasive Vertebral Compression Fracture Treatments 2011

Published: May, 2011

Product code: 192335

Introduction

Abstract

This report covers the following countries: US, Europe (France, Germany, Italy, Spain, and the UK), and Asia Pacific (Australia, Japan, and South Korea).

Methodology

The following report uses a number of methodologies to gather and present data and analysis. At the outset, a large survey of secondary sources is conducted. These sources act as the basis for the primary research stage, which builds and enhances the quantitative and qualitative attributes of the early research.

Secondary sources include:

• Government Sources:
  • Securities and Exchange Commission filings
  • Food and Drug Administration and patent filings
  • National Center for Health Statistics data
  • National Institute for Health and Clinical Excellence
  • Japanese Ministry of Health, Labour and Welfare
  • Korean Food and Drug Administration
  • Australian Medical Services Advisory Committee
• Minimally Invasive Vertebral Compression Fracture (MIVCF) Treatment Companies:
  • Annual reports, product brochures, corporate profiles, etc.
• Internal Databases and Reports:
  • Previous reports on similar/related sources
• General Internet Searches, Medical Literature, and Newspaper/Magazine Searches:
  • Identifying various centers of specialization and articles that might provide leads for primary research.

The secondary research stage builds the foundation for the primary research.

The primary research methodology has four steps:

Step 1: The first step involves an impartial scan of all the information gathered during the secondary research stage to determine its utility based on the specific requirements of this report. Each piece of information is, thus, either discarded or marked as high or low priority. It is then organized appropriately as determined by the structure and sectioning of the report.

Step 2: At this stage, early assumptions are formed as to the implications of the information for the various MIVCF treatment market segments. These assumptions are then used to determine hypotheses using both inductive and deductive approaches. On the quantitative front, these hypotheses result in full historical and projected market data sets (market sizes [procedures and US$] and market shares).

Step 3: At this stage, the research is in position for its most important primary phase - expert interviews. Throughout the secondary research, industry and medical experts are identified. These experts are now contacted by telephone and asked to participate in interviews on recent trends and developments in the industry. Interviews are either conducted at the time of the initial call or scheduled at the convenience of the expert. Interview questions are tailored to the expertise of the particular interviewee, although in most cases, the most important questions are asked of all experts. The questions are largely based on the assumptions and hypotheses developed in Step 2, which are then either augmented, discarded, or adjusted, based on the views and positions put forth. Attempts are made, whenever possible, to cross-check the views of various experts against each other and reach positions of consensus on issues and market numbers.

Step 4: The final stage of primary research involves individual and group analysis by Millennium Research Group. All research results are assessed and cross-checked thoroughly to determine their validity, relevance, and weight. From this process, qualitative conclusions are reached and data points finalized.

In addition to Steps 1 through 4 (as outlined above), the following “bottom-up” methodology was followed in developing forecast assumptions for this report.

A comprehensive breakdown of various MIVCF treatments was prepared using data from several sources including professional associations, government statistics, and private research/media sources. Industry experts and practitioners were consulted to ensure accuracy and verify observed trends. As a cross-check, total industry revenues available through 10-Ks and other sources were compared against modeled industry revenues.

Using the best estimates of industry experts, practitioners, private research/media sources, and in-house experts, year-by-year growth rates and average selling prices were applied individually to each subcategory to derive forecasts. These estimates were cross-checked by industry experts (marketing managers, product managers, CEOs, etc.) and further refined.

Overall findings were compared against market and procedure forecasts published by other sources to ensure reasonable estimates.

Table of Contents

TABLE OF CONTENTS

LIST OF EXHIBITS

EXECUTIVE SUMMARY

METHODOLOGY

1.0 VERTEBRAL COMPRESSION FRACTURE OVERVIEW

• 1.1 Anatomy of the Human Spine
• 1.2 Selected Spine Disorders
  • 1.2.1 Osteoporosis
  • 1.2.2 Rheumatoid Arthritis
  • 1.2.3 Kyphosis
  • 1.2.4 Traumatic Spine Disorders
  • 1.2.5 Spinal Tumor Disorders
• 1.3 Vertebral Compression Fractures
  • 1.3.1 Treatment Options
    • 1.3.1.1 Nonsurgical
    • 1.3.1.2 Surgical
    • 1.3.1.3 Noninvasive Approach
• 1.4 Vertebroplasty
  • 1.4.1 Approach
  • 1.4.2 Mechanism of Action
  • 1.4.3 Potential Complications
  • 1.4.4 Indications/Contraindications
• 1.5 Vertebral Augmentation
• 1.6 Vertebroplasty versus Vertebral Augmentation
• 1.7 Injectable Bone Cement
• 1.8 Cement Delivery Systems

2.0 GLOBAL MIVCF TREATMENT MARKET

• 2.1 Market Overview
• 2.2 Market Analysis
  • 2.2.1 Key Report Updates
  • 2.2.2 Economic Assumptions for the Forecast Period
  • 2.2.3 Procedures
  • 2.2.4 Market Forecast
  • 2.2.5 Market Drivers and Limiters
    • 2.2.5.1 Market Drivers
    • 2.2.5.2 Market Limiters
• 2.3 Competitive Analysis
  • 2.3.1 Competitive Landscape
  • 2.3.2 Market Shares
  • 2.3.3 Competitor Discussions (in Alphabetical Order)
    • ArthroCare
    • CareFusion
    • Cook Medical
    • DePuy Spine
    • Medtronic Spinal & Biologics
    • OptiMed
    • PENTAX
    • Stryker Pain Management
    • Synthes
    • Taeyeon Medical
    • Other
  • 2.3.4 New and Emerging Competitors
    • Alphatec Spine
    • AOI Medical
    • Benvenue Medical
    • Crosstrees Medical
    • DFine
    • Orthovita
    • Osseon Therapeutics
    • PANMed International
    • Soteira
    • Spineology
    • Spine Wave
    • Vexim

3.0 US MIVCF TREATMENT MARKET

• 3.1 Market Overview
• 3.2 Market Analysis
  • 3.2.1 Procedures
    • 3.2.1.1 Vertebroplasty Procedures
      • By Level
      • By Indication
      • By Physician Specialty
      • By Cement Type
      • By Approach
      • By Region of the Spine
      • By Facility Type
      • By Hospital Location
    • 3.2.1.2 Vertebral Augmentation Procedures
      • By Level
      • By Indication
      • By Physician Specialty
      • By Cement Type
      • By Approach
      • By Region of the Spine
      • By Facility Type
      • By Hospital Location
  • 3.2.2 Market Forecast
    • 3.2.2.1 MIVCF Treatment Bone Cement Market
    • 3.2.2.2 MIVCF Treatment Delivery System Market
  • 3.2.3 Market Drivers and Limiters
    • 3.2.3.1 Market Drivers
    • 3.2.3.2 Market Limiters
• 3.3 Competitive Analysis
  • 3.3.1 Competitive Landscape
  • 3.3.2 Market Shares

4.0 EUROPEAN MIVCF TREATMENT MARKET

• 4.1 Market Overview
• 4.2 Market Analysis
  • 4.2.1 Procedures
    • 4.2.1.1 By Country
    • 4.2.1.2 By Level
    • 4.2.1.3 By Indication
    • 4.2.1.4 By Physician Specialty
    • 4.2.1.5 By Cement Type
    • 4.2.1.6 By Approach
    • 4.2.1.7 By Region of the Spine
    • 4.2.1.8 By Facility Type (Germany, Italy, and the UK only)
  • 4.2.2 Market Forecast
  • 4.2.3 Market Drivers and Limiters
    • 4.2.3.1 Market Drivers
    • 4.2.3.2 Market Limiters
• 4.3 Competitive Analysis
  • 4.3.1 Competitive Landscape
  • 4.3.2 Market Shares
• 4.4 French MIVCF Treatment Market
  • 4.4.1 Market Analysis
  • 4.4.2 Market Drivers and Limiters
    • 4.4.2.1 Market Drivers
    • 4.4.2.2 Market Limiters
  • 4.4.3 Competitive Analysis
    • 4.4.3.1 Competitive Landscape
    • 4.4.3.2 Market Shares
• 4.5 German MIVCF Treatment Market
  • 4.5.1 Market Analysis
  • 4.5.2 Market Drivers and Limiters
    • 4.5.2.1 Market Drivers
    • 4.5.2.2 Market Limiters
  • 4.5.3 Competitive Analysis
    • 4.5.3.1 Competitive Landscape
    • 4.5.3.2 Market Shares
• 4.6 Italian MIVCF Treatment Market
  • 4.6.1 Market Analysis
  • 4.6.2 Market Drivers and Limiters
    • 4.6.2.1 Market Drivers
    • 4.6.2.2 Market Limiters
  • 4.6.3 Competitive Analysis
    • 4.6.3.1 Competitive Landscape
    • 4.6.3.2 Market Shares
• 4.7 UK MIVCF Treatment Market
  • 4.7.1 Market Analysis
  • 4.7.2 Market Drivers and Limiters
    • 4.7.2.1 Market Drivers
    • 4.7.2.2 Market Limiters
  • 4.7.3 Competitive Analysis
    • 4.7.3.1 Competitive Landscape
    • 4.7.3.2 Market Shares

5.0 ASIA PACIFIC MIVCF TREATMENT MARKET

• 5.1 Market Overview
• 5.2 Market Analysis
  • 5.2.1 Procedures
    • 5.2.1.1 By Level
    • 5.2.1.2 By Indication
    • 5.2.1.3 By Physician Specialty
    • 5.2.1.4 By Cement Type (Australia and Japan Only)
    • 5.2.1.5 By Approach (Australia and Japan Only)
    • 5.2.1.6 By Region of Spine (Australia and Japan Only)
    • 5.2.1.7 By Facility Type (Australia only)
  • 5.2.2 Market Forecast
    • 5.2.2.1 By Procedure
    • 5.2.2.2 By Country
  • 5.2.3 Market Drivers and Limiters
    • 5.2.3.1 Market Drivers
    • 5.2.3.2 Market Limiters
• 5.3 Competitive Analysis
  • 5.3.1 Competitive Landscape
  • 5.3.2 Market Shares
• 5.4 Australian MIVCF Treatment Market
  • 5.4.1 Market Analysis
  • 5.4.2 Market Drivers and Limiters
    • 5.4.2.1 Market Drivers
    • 5.4.2.2 Market Limiters
  • 5.4.3 Competitive Analysis
    • 5.4.3.1 Competitive Landscape
    • 5.4.3.2 Market Shares
• 5.5 Japanese MIVCF Treatment Market
  • 5.5.1 Market Analysis
  • 5.5.2 Market Drivers and Limiters
    • 5.5.2.1 Market Drivers
    • 5.5.2.2 Market Limiters
  • 5.5.3 Competitive Analysis
    • 5.5.3.1 Competitive Landscape
    • 5.5.3.2 Market Shares
• 5.6 South Korean MIVCF Treatment Market
  • 5.6.1 Market Analysis
  • 5.6.2 Market Drivers and Limiters
    • 5.6.2.1 Market Drivers
    • 5.6.2.2 Market Limiters
  • 5.6.3 Competitive Analysis
    • 5.6.3.1 Competitive Landscape
    • 5.6.3.2 Market Shares

APPENDIX A: MRG ACRONYMS AND INITIALISMS

APPENDIX B: SPANISH VERTEBROPLASTY MARKET

APPENDIX C: POPULATION STATISTICS

APPENDIX D: OSTEOPOROSIS EPIDEMIOLOGY

APPENDIX E: SUPPLEMENTAL EXHIBITS

List of Exhibits

• EXECUTIVE SUMMARY
• Exhibit 1: MIVCF Treatment Market, by Segment, Global (US$), 2008 - 2014
• Exhibit 2: MIVCF Treatment Market, by Segment, US (US$), 2008 - 2014
• Exhibit 3: MIVCF Treatments, by Country, Europe, 2008 - 2014
• Exhibit 4: MIVCF Treatment Market, by Segment, Asia Pacific (US$), 2008 - 2014
• Exhibit 5: Leading Competitors in the MIVCF Treatment Market, Global, 2009
• METHODOLOGY
• Exhibit 6: Currency Exchange Rates, 2009
• CHAPTER 1: VERTEBRAL COMPRESSION FRACTURE OVERVIEW
• Exhibit 7: Roles of the Spinal Column
• Exhibit 8: Potential Complications of Vertebroplasty
• Exhibit 9: Selected Contraindications to Vertebroplasty
• Exhibit 10: Vertebroplasty versus Balloon Kyphoplasty
• Exhibit 11: Selected Bone Cements for MIVCF Treatments
• Exhibit 12: Selected Cement Delivery Systems and Accessories
• CHAPTER 2: GLOBAL MIVCF TREATMENT MARKET
• Exhibit 13: MIVCF Treatment Market, Global (US$), 2008 - 2014
• Exhibit 14: Key Report Updates, 2010
• Exhibit 15: MIVCF Treatments, by Segment, Global, 2008 - 2014
• Exhibit 16: MIVCF Treatments, by Segment and Region, Global, 2008 - 2014
• Exhibit 17: MIVCF Treatments, by Region, Global, 2008 - 2014
• Exhibit 18: MIVCF Treatment Market, by Segment, Global (US$), 2008 - 2014
• Exhibit 19: MIVCF Treatment Market, by Segment and Region, Global (US$), 2008 - 2014
• Exhibit 20: MIVCF Treatment Market, by Region, Global (US$), 2008 - 2014
• Exhibit 21: Drivers and Limiters of the MIVCF Treatment Market, Global
• Exhibit 22: Select Clinical Trials Studying MIVCF Treatments, Global, 2009
• Exhibit 23: Select Clinical Trials Studying MIVCF Treatments, Global, 2009 (cont' d)
• Exhibit 24: Select Clinical Trials Studying MIVCF Treatments, Global, 2009 (cont' d)
• Exhibit 25: Leading Competitors in the MIVCF Treatment Market, by Segment, as a % of Total, Global, 2009
• Exhibit 26: Leading Competitors in the Vertebroplasty Market, as a % of Total, Global, 2009
• CHAPTER 3: US MIVCF TREATMENT MARKET
• Exhibit 27: MIVCF Treatments, by Segment, US, 2008 - 2014 (Graphical Format)
• Exhibit 28: MIVCF Treatments, by Segment, US, 2008 - 2014 (Tabular Format)
• Exhibit 29: MIVCF Treatments, by Segment and Level, as a % of Total, US, 2008 - 2014
• Exhibit 30: MIVCF Treatment Levels, by Segment, US, 2008 - 2014
• Exhibit 31: MIVCF Treatments, by Segment and Indication, as a % of Total, US, 2008 - 2014
• Exhibit 32: MIVCF Treatments, by Segment and Physician Specialty, as a % of Total, US, 2008 - 2014
• Exhibit 33: MIVCF Treatments, by Segment and Cement Type, as a % of Total, US, 2008 - 2014
• Exhibit 34: MIVCF Treatments, by Segment and Approach, as a % of Total, US, 2008 - 2014
• Exhibit 35: MIVCF Treatments, by Segment and Region of Spine, as a % of Total, US, 2008 - 2014
• Exhibit 36: MIVCF Treatments, by Segment and Facility Type, as a % of Total, US, 2008 - 2014
• Exhibit 37: MIVCF Treatments, by Segment and Hospital Location, as a % of Total, US, 2008 - 2014
• Exhibit 38: MIVCF Treatment Market, by Segment, US (US$), 2008 - 2014
• Exhibit 39: MIVCF Treatment Market Growth, by Segment, US, 2009 - 2014
• Exhibit 40: MIVCF Treatment ASPs, by Segment and Component, US (US$), 2008 - 2014
• Exhibit 41: MIVCF Treatment Bone Cement Market, by Segment, US (US$), 2008 - 2014
• Exhibit 42: MIVCF Treatment Bone Cement Market Growth, by Segment, US, 2009 - 2014
• Exhibit 43: MIVCF Treatment Delivery System Market, by Segment, US (US$), 2008 - 2014
• Exhibit 44: MIVCF Treatment Delivery System Market Growth, by Segment, US, 2009 - 2014
• Exhibit 45: Drivers and Limiters of the MIVCF Treatment Market, US
• Exhibit 46: Leading Competitors in the MIVCF Treatment Market, by Segment, as a % of Total, US, 2009
• CHAPTER 4: EUROPEAN MIVCF TREATMENT MARKET
• Exhibit 47: MIVCF Treatment Market, Europe (US$), 2008 - 2014
• Exhibit 48: MIVCF Treatments, by Segment, Europe, 2008 - 2014
• Exhibit 49: MIVCF Treatments, by Segment and Country, Europe, 2008 - 2014
• Exhibit 50: MIVCF Treatments, by Country, Europe, 2008 - 2014
• Exhibit 51: MIVCF Treatment Levels, by Segment, Europe, 2008 - 2014
• Exhibit 52: MIVCF Treatment Market, by Segment, Europe, (US$ and € ), 2008 - 2014
• Exhibit 53: Vertebroplasty Market, by Country, Europe (US$ and € ), 2008 - 2014
• Exhibit 54: Vertebral Augmentation Market, by Country, Europe (US$ and € ), 2008 - 2014
• Exhibit 55: MIVCF Treatment Bone Cement Market, by Segment, Europe, (US$ and € ), 2008 - 2014
• Exhibit 56: MIVCF Treatment Bone Cement Market, by Country, Europe (US$ and € ), 2008 - 2014
• Exhibit 57: MIVCF Treatment Delivery System Market, by Segment, Europe, (US$ and € ), 2008 - 2014
• Exhibit 58: MIVCF Treatment Delivery System Market, by Country, Europe (US$ and € ), 2008 - 2014
• Exhibit 59: Drivers and Limiters of the MIVCF Treatment Market, Europe
• Exhibit 60: Leading Competitors in the MIVCF Treatment Market, by Segment, as a % of Total, Europe, 2009
• Exhibit 61: Leading Competitors in the MIVCF Treatment Market, by Country, as a % of Total, Europe, 2009
• Exhibit 62: MIVCF Treatments, by Segment, France, 2008 - 2014
• Exhibit 63: MIVCF Treatments, by Segment and Level, as a % of Total, France, 2008 - 2014
• Exhibit 64: MIVCF Treatment Levels, by Segment, France, 2008 - 2014
• Exhibit 65: Vertebroplasty Treatments, by Indication, as a % of Total, France, 2008 - 2014
• Exhibit 66: Vertebroplasty Treatments, by Physician Specialty, as a % of Total, France, 2008 - 2014
• Exhibit 67: Vertebroplasty Treatments, by Cement Type, as a % of Total, France, 2008 - 2014
• Exhibit 68: Vertebroplasty Treatments, by Approach, as a % of Total, France, 2008 - 2014
• Exhibit 69: Vertebroplasty Treatments, by Region of Spine, as a % of Total, France, 2008 - 2014
• Exhibit 70: MIVCF Treatment Market, by Segment, France (US$ and € ), 2008 - 2014
• Exhibit 71: MIVCF Treatment Market Growth, by Segment, France, 2009 - 2014
• Exhibit 72: MIVCF Treatment ASPs, by Segment and Component, France (US$ and € ), 2008 - 2014
• Exhibit 73: MIVCF Treatment Bone Cement Market, by Segment, France (US$), 2008 - 2014
• Exhibit 74: MIVCF Treatment Bone Cement Market, by Segment, France (€ ), 2008 - 2014
• Exhibit 75: MIVCF Treatment Bone Cement Market Growth, by Segment, France, 2009 - 2014
• Exhibit 76: MIVCF Treatment Delivery System Market, by Segment, France (US$), 2008 - 2014
• Exhibit 77: MIVCF Treatment Delivery System Market, by Segment, France (€ ), 2008 - 2014
• Exhibit 78: MIVCF Treatment Delivery System Market Growth, by Segment, France, 2009 - 2014
• Exhibit 79: Drivers and Limiters of the MIVCF Treatment Market, France
• Exhibit 80: Leading Competitors in the MIVCF Treatment Market, by Segment, as a % of Total, France, 2009
• Exhibit 81: MIVCF Treatments, by Segment, Germany, 2008 - 2014
• Exhibit 82: MIVCF Treatments, by Segment and Level, as a % of Total, Germany, 2008 - 2014
• Exhibit 83: MIVCF Treatment Levels, by Segment, Germany, 2008 - 2014
• Exhibit 84: MIVCF Treatments, by Segment and Indication, as a % of Total, Germany, 2008 - 2014
• Exhibit 85: MIVCF Treatments, by Segment and Physician Specialty, as a % of Total, Germany, 2008 - 2014
• Exhibit 86: MIVCF Treatments, by Segment and Cement Type, as a % of Total, Germany, 2008 - 2014
• Exhibit 87: MIVCF Treatments, by Segment and Approach, as a % of Total, Germany, 2008 - 2014
• Exhibit 88: MIVCF Treatments, by Segment and Region of Spine, as a % of Total, Germany, 2008 - 2014
• Exhibit 89: MIVCF Treatments, by Segment and Facility Type, as a % of Total, Germany, 2008 - 2014
• Exhibit 90: MIVCF Treatment Market, by Segment, Germany (US$ and € ), 2008 - 2014
• Exhibit 91: MIVCF Treatment Market Growth, by Segment, Germany, 2009 - 2014
• Exhibit 92: MIVCF Treatment ASPs, by Segment and Component, Germany (US$ and € ), 2008 - 2014
• Exhibit 93: MIVCF Treatment Bone Cement Market, by Segment, Germany (US$), 2008 - 2014
• Exhibit 94: MIVCF Treatment Bone Cement Market, by Segment, Germany (€ ), 2008 - 2014
• Exhibit 95: MIVCF Treatment Bone Cement Market Growth, by Segment, Germany, 2009 - 2014
• Exhibit 96: MIVCF Treatment Delivery System Market, by Segment, Germany (US$), 2008 - 2014
• Exhibit 97: MIVCF Treatment Delivery System Market, by Segment, Germany (€ ), 2008 - 2014
• Exhibit 98: MIVCF Treatment Delivery System Market Growth, by Segment, Germany, 2009 - 2014
• Exhibit 99: Drivers and Limiters of the MIVCF Treatment Market, Germany
• Exhibit 100: Leading Competitors in the MIVCF Treatment Market, by Segment, as a % of Total, Germany, 2009
• Exhibit 101: MIVCF Treatments, by Segment, Italy, 2008 - 2014
• Exhibit 102: MIVCF Treatments, by Segment and Level, as a % of Total, Italy, 2008 - 2014
• Exhibit 103: MIVCF Treatment Levels, by Segment, Italy, 2008 - 2014
• Exhibit 104: MIVCF Treatments, by Segment and Indication, as a % of Total, Italy, 2008 - 2014
• Exhibit 105: MIVCF Treatments, by Segment and Physician Specialty, as a % of Total, Italy, 2008 - 2014
• Exhibit 106: Vertebroplasty Treatments, by Cement Type, as a % of Total, Italy, 2008 - 2014
• Exhibit 107: Vertebroplasty Treatments, by Approach, as a % of Total, Italy, 2008 - 2014
• Exhibit 108: Vertebroplasty Treatments, by Region of the Spine, as a % of Total, Italy, 2008 - 2014
• Exhibit 109: Vertebroplasty Treatments, by Facility Type, as a % of Total, Italy, 2008 - 2014
• Exhibit 110: MIVCF Treatment Market, by Segment, Italy (US$ and € ), 2008 - 2014
• Exhibit 111: MIVCF Treatment Market Growth, by Segment, Italy, 2009 - 2014
• Exhibit 112: MIVCF Treatment ASPs, by Segment and Component, Italy (US$ and € ), 2008 - 2014
• Exhibit 113: MIVCF Treatment Bone Cement Market, by Segment, Italy (US$), 2008 - 2014
• Exhibit 114: MIVCF Treatment Bone Cement Market, by Segment, Italy (€ ), 2008 - 2014
• Exhibit 115: MIVCF Treatment Bone Cement Market Growth, by Segment, Italy, 2009 - 2014
• Exhibit 116: MIVCF Treatment Delivery System Market, by Segment, Italy (US$), 2008 - 2014
• Exhibit 117: MIVCF Treatment Delivery System Market, by Segment, Italy (€ ), 2008 - 2014
• Exhibit 118: MIVCF Treatment Delivery System Market Growth, by Segment, Italy, 2009 - 2014
• Exhibit 119: Drivers and Limiters of the MIVCF Treatment Market, Italy
• Exhibit 120: Leading Competitors in the MIVCF Treatment Market, by Segment, as a % of Total, Italy, 2009
• Exhibit 121: MIVCF Treatments, by Segment, UK, 2008 - 2014
• Exhibit 122: MIVCF Treatments, by Segment and Level, as a % of Total, UK, 2008 - 2014
• Exhibit 123: MIVCF Treatment Levels, by Segment, UK, 2008 - 2014
• Exhibit 124: MIVCF Treatments, by Segment and Indication, as a % of Total, UK, 2008 - 2014
• Exhibit 125: MIVCF Treatments, by Segment and Physician Specialty, as a % of Total, UK, 2008 - 2014
• Exhibit 126: Vertebroplasty Treatments, by Cement Type, as a % of Total, UK, 2008 - 2014
• Exhibit 127: Vertebroplasty Treatments, by Approach, as a % of Total, UK, 2008 - 2014
• Exhibit 128: Vertebroplasty Treatments, by Region of Spine, as a % of Total, UK, 2008 - 2014
• Exhibit 129: Vertebroplasty Treatments, by Facility Type, as a % of Total, UK, 2008 - 2014
• Exhibit 130: MIVCF Treatment Market, by Segment, UK (US$), 2008 - 2014
• Exhibit 131: MIVCF Treatment Market, by Segment, UK (€ ), 2008 - 2014
• Exhibit 132: MIVCF Treatment Market, by Segment, UK (£), 2008 - 2014
• Exhibit 133: MIVCF Treatment Market Growth, by Segment, UK, 2009 - 2014
• Exhibit 134: MIVCF Treatment ASPs, by Segment and Component, UK (US$, € , and £), 2008 - 2014
• Exhibit 135: MIVCF Treatment Bone Cement Market, by Segment, UK (US$), 2008 - 2014
• Exhibit 136: MIVCF Treatment Bone Cement Market, by Segment, UK (€ ), 2008 - 2014
• Exhibit 137: MIVCF Treatment Bone Cement Market, by Segment, UK (£), 2008 - 2014
• Exhibit 138: MIVCF Treatment Bone Cement Market Growth, by Segment, UK, 2009 - 2014
• Exhibit 139: MIVCF Treatment Delivery System Market, by Segment, UK (US$), 2008 - 2014
• Exhibit 140: MIVCF Treatment Delivery System Market, by Segment, UK (€ ), 2008 - 2014
• Exhibit 141: MIVCF Treatment Delivery System Market, by Segment, UK (£), 2008 - 2014
• Exhibit 142: MIVCF Treatment Delivery System Market Growth, by Segment, UK, 2009 - 2014
• Exhibit 143: Drivers and Limiters of the MIVCF Treatment Market, UK
• Exhibit 144: Leading Competitors in the MIVCF Treatment Market, by Segment, as a % of Total, UK, 2009
• CHAPTER 5: ASIA PACIFIC MIVCF TREATMENT MARKET
• Exhibit 145: MIVCF Treatment Market, by Country, Asia Pacific (US$), 2008 - 2014
• Exhibit 146: MIVCF Treatments, by Segment, Asia Pacific, 2008 - 2014
• Exhibit 147: MIVCF Treatments, by Segment and Country, Asia Pacific, 2008 - 2014
• Exhibit 148: MIVCF Treatments, by Country, Asia Pacific, 2008 - 2014
• Exhibit 149: MIVCF Treatment Levels, by Segment, Asia Pacific, 2008 - 2014
• Exhibit 150: MIVCF Treatment Market, by Segment, Asia Pacific, (US$), 2008 - 2014
• Exhibit 151: MIVCF Treatment Market, by Segment and Country, Asia Pacific (US$), 2008 - 2014
• Exhibit 152: MIVCF Treatment Bone Cement Market, by Segment, Asia Pacific (US$), 2008 - 2014
• Exhibit 153: MIVCF Treatment Bone Cement Market, by Country, Asia Pacific (US$), 2008 - 2014
• Exhibit 154: MIVCF Treatment Delivery System Market, by Segment, Asia Pacific, (US$), 2008 - 2014
• Exhibit 155: MIVCF Treatment Delivery System Market, by Country, Asia Pacific (US$), 2008 - 2014
• Exhibit 156: Drivers and Limiters of the MIVCF Treatment Market, Asia Pacific
• Exhibit 157: Leading Competitors in the MIVCF Treatment Market, by Segment, as a % of Total, Asia Pacific, 2009
• Exhibit 181: MIVCF Treatments, by Segment and Level, as a % of Total, Japan, 2008 - 2014
• Exhibit 182: MIVCF Treatment Levels, by Segment, Japan, 2008 - 2014
• Exhibit 183: MIVCF Treatments, by Segment and Indication, as a % of Total, Japan, 2008 - 2014
• Exhibit 184: MIVCF Treatments, by Segment and Physician Specialty, as a % of Total, Japan, 2008 - 2014
• Exhibit 185: MIVCF Treatments, by Segment and Cement Type, as a % of Total, Japan, 2008 - 2014
• Exhibit 186: MIVCF Treatments, by Segment and Approach, as a % of Total, Japan, 2008 - 2014
• Exhibit 187: MIVCF Treatments, by Segment and Region of Spine, as a % of Total, Japan, 2008 - 2014
• Exhibit 188: MIVCF Treatment Market, by Segment, Japan (US$ and ¥), 2008 -2014
• Exhibit 189: MIVCF Treatment Market Growth, by Segment, Japan, 2009 - 2014
• Exhibit 190: MIVCF Treatment ASPs, by Segment and Component, Japan (US$ and ¥), 2008 - 2014
• Exhibit 191: MIVCF Treatment Bone Cement Market, by Segment, Japan (US$), 2008 - 2014
• Exhibit 192: MIVCF Treatment Bone Cement Market, by Segment, Japan (¥), 2008 - 2014
• Exhibit 193: MIVCF Treatment Bone Cement Market Growth, by Segment, Japan, 2009 - 2014
• Exhibit 194: MIVCF Treatment Delivery System Market, by Segment, Japan (US$), 2008 - 2014
• Exhibit 195: MIVCF Treatment Delivery System Market, by Segment, Japan (¥), 2008 - 2014
• Exhibit 196: MIVCF Treatment Delivery System Market Growth, by Segment, Japan, 2009 - 2014
• Exhibit 197: Drivers of the MIVCF Treatment Market, Japan
• Exhibit 198: Leading Competitors in the MIVCF Treatment Market, as a % of Total, Japan, 2009
• Exhibit 199: MIVCF Treatments, by Segment, South Korea, 2008 - 2014
• Exhibit 200: MIVCF Treatments, by Segment and Level, as a % of Total, South Korea, 2008 - 2014
• Exhibit 201: MIVCF Treatment Levels, by Segment, South Korea, 2008 - 2014
• Exhibit 202: MIVCF Treatments, by Segment and Indication, as a % of Total, South Korea, 2008 - 2014
• Exhibit 203: MIVCF Treatments, by Segment and Physician Specialty, as a % of Total, South Korea, 2008 - 2014
• Exhibit 204: MIVCF Treatment Market, by Segment, South Korea (US$ and KRW), 2008 - 2014
• Exhibit 205: MIVCF Market Growth, by Segment, South Korea, 2009 - 2014
• Exhibit 206: MIVCF Treatment ASPs, by Segment and Component, South Korea (US$ and KRW), 2008 - 2014
• Exhibit 207: MIVCF Treatment Bone Cement Market, by Segment, South Korea (US$), 2008 - 2014
• Exhibit 208: MIVCF Treatment Bone Cement Market, by Segment, South Korea (KRW), 2008 - 2014
• Exhibit 209: MIVCF Treatment Bone Cement Market Growth, by Segment, South Korea, 2009 - 2014
• Exhibit 210: MIVCF Treatment Delivery System Market, by Segment, South Korea (US$), 2008 - 2014
• Exhibit 211: MIVCF Treatment Delivery System Market, by Segment, South Korea (KRW), 2008 - 2014
• Exhibit 212: MIVCF Treatment Delivery System Market Growth, by Segment, South Korea, 2009 - 2014
• Exhibit 213: Drivers and Limiters of the MIVCF Treatment Market, South Korea
• Exhibit 214: Leading Competitors in the MIVCF Treatment Market, by Segment, as a % of Total, South Korea, 2009
• APPENDIX B: SPANISH VERTEBROPLASTY MARKET
• Exhibit 215: Vertebroplasty Market, Spain (US$ and € ), 2008 - 2014
• APPENDIX C: POPULATION STATISTICS
• Exhibit 216: Population, by Age Group, US, 2008-2014
• Exhibit 217: Population, by Age Group, France, 2008-2014
• Exhibit 218: Population, by Age Group, Germany, 2008-2014
• Exhibit 219: Population, by Age Group, Italy, 2008-2014
• Exhibit 220: Population, by Age Group, UK, 2008-2014
• Exhibit 221: Population, by Age Group, Spain, 2008-2014
• Exhibit 222: Population, by Age Group, Australia, 2008-2014
• Exhibit 223: Population, by Age Group, Japan, 2008-2014
• Exhibit 224: Population, by Age Group, South Korea, 2008-2014
• APPENDIX D: OSTEOPOROSIS EPIDEMIOLOGY
• Exhibit 225: Prevalence of Osteoporosis, by Age Group, US, 2008 - 2014
• Exhibit 226: Prevalence of Osteoporosis, by Age Group, France, 2008 - 2014
• Exhibit 227: Prevalence of Osteoporosis, by Age Group, Germany, 2008 - 2014
• Exhibit 228: Prevalence of Osteoporosis, by Age Group, Italy, 2008 - 2014
• Exhibit 229: Prevalence of Osteoporosis, by Age Group, Spain, 2008 - 2014
• Exhibit 230: Prevalence of Osteoporosis, by Age Group, UK, 2008 - 2014
• Exhibit 231: Prevalence of Osteoporosis, by Age Group, Japan, 2008 - 2014
• APPENDIX E: SUPPLEMENTAL EXHIBITS
• Exhibit 232: MIVCF Treatment Market, by Segment, Global (US$), 2008 - 2014 (Detailed Format)
• Exhibit 233: MIVCF Treatment Market, by Segment, US (US$), 2008 - 2014 (Detailed Format)
• Exhibit 234: MIVCF Treatments, by Country, Europe, 2008 - 2014 (Detailed Format)
• Exhibit 235: MIVCF Treatment Market, by Segment, Asia Pacific (US$), 2008 - 2014 (Detailed Format)

Related Reports